Follow
Sorin Avram
Sorin Avram
Institute of Chemistry Timisoara of Romanian Academy, Department of Computational Chemistry
Verified email at acad-icht.tm.edu.ro - Homepage
Title
Cited by
Cited by
Year
DrugCentral 2021 supports drug discovery and repositioning
S Avram, CG Bologa, J Holmes, G Bocci, TB Wilson, DT Nguyen, ...
Nucleic acids research 49 (D1), D1160-D1169, 2021
1562021
Quantitative estimation of pesticide-likeness for agrochemical discovery
S Avram, S Funar-Timofei, A Borota, SR Chennamaneni, AK Manchala, ...
Journal of cheminformatics 6, 1-11, 2014
802014
Design, synthesis and pharmaco-toxicological assessment of 5-mercapto-1, 2, 4-triazole derivatives with antibacterial and antiproliferative activity
M Mioc, C Soica, V Bercean, S Avram, M Balan‑Porcarasu, D Coricovac, ...
International journal of oncology 50 (4), 1175-1183, 2017
362017
Predictive models for fast and effective profiling of kinase inhibitors
A Bora, S Avram, I Ciucanu, M Raica, S Avram
Journal of Chemical Information and Modeling 56 (5), 895-905, 2016
242016
Design, Synthesis and Biological Activity Evaluation of S-Substituted 1H-5-Mercapto-1,2,4-Triazole Derivatives as Antiproliferative Agents in Colorectal Cancer
M Mioc, S Avram, V Bercean, L Kurunczi, RM Ghiulai, C Oprean, ...
Frontiers in chemistry 6, 373, 2018
222018
DrugCentral 2023 extends human clinical data and integrates veterinary drugs
S Avram, TB Wilson, R Curpan, L Halip, A Borota, A Bora, CG Bologa, ...
Nucleic acids research 51 (D1), D1276-D1287, 2023
202023
Modelling Kinase Inhibition Using Highly Confident Data Sets
S Avram, A Bora, L Halip, R Curpan
Journal of chemical information and modeling 58 (5), 957-967, 2018
192018
Exploring the biological promiscuity of high-throughput screening hits through DFT calculations
R Curpăn, S Avram, R Vianello, C Bologa
Bioorganic & medicinal chemistry 22 (8), 2461-2468, 2014
182014
PLS-DA-docking optimized combined energetic terms (PLSDA-DOCET) protocol: A brief evaluation
S Avram, LM Pacureanu, E Seclaman, A Bora, L Kurunczi
Journal of chemical information and modeling 51 (12), 3169-3179, 2011
182011
ColBioS-FlavRC: A collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes
SI Avram, LM Pacureanu, A Bora, L Crisan, S Avram, L Kurunczi
Journal of Chemical Information and Modeling 54 (8), 2360-2370, 2014
172014
QSAR study and molecular docking on indirubin inhibitors of Glycogen Synthase Kinase-3
L Crisan, L Pacureanu, A Bora, S Avram, L Kurunczi, Z Simon
Central European Journal of Chemistry 11, 63-77, 2013
172013
Off-patent drug repositioning
S Avram, R Curpan, L Halip, A Bora, TI Oprea
Journal of chemical information and modeling 60 (12), 5746-5753, 2020
162020
Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors
L Crisan, S Avram, L Pacureanu
Molecular Diversity 21, 385-405, 2017
162017
Retrospective group fusion similarity search based on eROCE evaluation metric
SI Avram, L Crisan, A Bora, LM Pacureanu, S Avram, L Kurunczi
Bioorganic & Medicinal Chemistry 21 (5), 1268-1278, 2013
162013
Novel drug targets in 2021.
S Avram, L Halip, R Curpan, TI Oprea
Nature reviews. Drug discovery 21 (5), 328-328, 2022
152022
Novel drug targets in 2019.
S Avram, L Halip, R Curpan, TI Oprea
Nature Reviews Drug Discovery 19 (5), 300-301, 2020
142020
PLS and shape-based similarity analysis of maleimides–GSK-3 inhibitors
L Crisan, L Pacureanu, S Avram, A Bora, S Avram, L Kurunczi
Journal of enzyme inhibition and medicinal chemistry 29 (4), 599-610, 2014
132014
Novel drug targets in 2020
S Avram, L Halip, R Curpan, TI Oprea
Nature reviews. Drug discovery 20 (5), 333, 2021
92021
Portraying the selectivity of GSK-3 inhibitors towards CDK-2 by 3D similarity and molecular docking
L Pacureanu, S Avram, A Bora, L Kurunczi, L Crisan
Structural Chemistry 30 (3), 911-923, 2019
72019
Modeling of 2-Pyridin-3-yl-Benzo [d][1, 3] Oxazin-4-one Derivatives by Several Conformational Searching Tools and Molecular Docking
M Goodarzia, A Borab, A Borotab, S Funar-Timofeib, S Avramb, ...
Current Pharmaceutical Design 19 (12), 2194-203, 2013
72013
The system can't perform the operation now. Try again later.
Articles 1–20